Interestingly, however, the breast cancer case (P9) harboring the novel c.1350G > A variant in exon 10 of SMAD4, predicted to affect ESEs, had a significant expression increase by almost five-fold that was not observed in any other samples examined, indicating that the full length transcript is preferentially over-produced. The gene discussed is SMAD4; the disease is breast cancer.